HIGHLIGHTS
- who: Jialu Xu from the University ofCancer Center, United States have published the paper: Editorial: Emerging engineering approaches in cancer immunotherapy, in the Journal: (JOURNAL) of 24/08/2022
SUMMARY
Cancer immunotherapy, immunoengineering, Biomaterails, immune checkpoint block therapy, T_cell therapeutics Received CITATION Frontiers in Oncology To improve the efficacy of cancer immunotherapy and reduce the occurrence of immune-related adverse reactions, emerging engineering approaches have been explored for cancer immunotherapy. This Research Topic covers a range of novel engineering approaches for cancer immunotherapy, including engineered T_cells therapy (Xu et_al), bacteria-based synergistic therapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.